Dose Escalation Using Hypoxia-adjusted Radiotherapy
Status:
Recruiting
Trial end date:
2028-04-01
Target enrollment:
Participant gender:
Summary
DE-HyART is a phase II clinical trial aimed at understanding the effects of escalating
radiation doses to hypoxic sub-volumes inherent to squamous cell head and neck cancer. The
study is aimed at assessing locoregional control, feasibility, and acceptable toxicity with
such a strategy.
Phase:
Phase 2
Details
Lead Sponsor:
Rajiv Gandhi Cancer Institute & Research Center, India